116167-27-2

Basic information

• Product Name: 1-HEXYL-5-OXO-3-PYRROLIDINECARBOXYLIC ACID
• Synonyms: 1-HEXYL-5-OXO-3-PYRROLIDINECARBOXYLIC ACID;1-HEXYL-5-OXO-PYRROLIDINE-3-CARBOXYLIC ACID;3-pyrrolidinecarboxylic acid, 1-hexyl-5-oxo-;1-hexyl-5-keto-pyrrolidine-3-carboxylic acid
• CAS NO: 116167-27-2
• Molecular Formula: C11H19NO3
• Molecular Weight: 213.27
• Mol File: 116167-27-2.mol
• Article Data: 1

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 1-HEXYL-5-OXO-3-PYRROLIDINECARBOXYLIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: 1-HEXYL-5-OXO-3-PYRROLIDINECARBOXYLIC ACID(116167-27-2)
• EPA Substance Registry System: 1-HEXYL-5-OXO-3-PYRROLIDINECARBOXYLIC ACID(116167-27-2)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 116167-27-2(Hazardous Substances Data)

Usage

Structure

A chemical compound consisting of a six-carbon hexyl chain, a five-membered pyrrolidone ring, and a carboxylic acid group attached to the carbon chain.

Classification

A derivative of pyrrolidone.

Usage

Commonly used as a building block in the synthesis of various pharmaceuticals and other organic compounds.

Applications

Production of polymers, including nylon, and as a stabilizer in cosmetic and personal care products.

Potential Properties

Studied for its potential antimicrobial and antioxidant properties.

Relevant articles and documents

CYCLIC AMINE BASE-1 INHIBITORS HAVING A HETEROCYCLIC SUBSTITUENT

Disclosed are novel compounds of the formula (I)or a pharmaceutically acceptable salt or solvate thereof, wherein R1 is formula (I) X is -0-, -C(R14)2- or -N(R)-; Z is -C(R14)2- or -N(R)-; t is 0, 1, 2 or 3; each R and R2 is independently H, alkyl, cycloalkyl, cycloalkylalkyl, aryl, heteroaryl, heterocycloalkyl, arylalkyl, heteroarylalkyl, heterocycloalkylalkyl, alkenyl or alkynyl; each R14 is H, alkyl, alkenyl, alkynyl, halo, -CN, haloalkyl, cycloalkyl, cycloalkylalkyl, aryl, heteroaryl, heterocycloalkyl, arylalkyl, heteroarylalkyl, heterocycloalkylalkyl, -OR35, -N(R24)(R25)or -SR35; R41 is alkyl, cycloalkyl, -S02(alkyl), -C(O)-alkyl, -C(O)-cycloalkyl or -alkyl-NH-C(O)CH3; and the remaining variables are as defined in the specification. Also disclosed are pharmaceutical compositions comprising the compounds of formula I and methods of treating cognitive or neurodegenerative diseases with compounds of formula (I). Also disclosed are pharmaceutical compositions and methods of treatment comprising compounds of formula I in combination with other agents useful in treating cognitive or neurodegenerative diseases.